Biotech China 2014

Pharmacology: H. Lee Moffitt Cancer Center

Total Score People Score Events Score
4 4 2
Date Event Presentation Speakers
May 30, 2008 ASCO Annual'08 Meeting lung cancer-- Biomarkers of Resistance and Response in Non-Small Cell Lung Cancer Gerold Bepler
lung cancer-- Management of Oligometastatic Disease in Lung Cancer (M11) Lary Robinson
melanoma/skin cancers-- New Approaches to Melanoma Therapy Jeffrey Weber
tumor biology-- Biomarkers of Resistance and Response in Non-Small Cell Lung Cancer Gerold Bepler
meet the professor sessions-- Management of Oligometastatic Disease in Lung Cancer (M11) Lary Robinson
October 16, 2007 Inaugural HDAC inhibitors: Meeting the Challenges of Chemical Development of HDAC Inhibitors Oct (16 -17) MOLECULAR MODE-OF-ACTION AND BIOMARKER STRATEGIES FOR CLINICAL DEVELOPMENT(11:10-16:30) Pamela N. Munster
MOLECULAR MODE-OF-ACTION AND BIOMARKER STRATEGIES FOR CLINICAL DEVELOPMENT: Panel Discussion- Are HDAC Inhibitors Proving Their Worth in the Clinic? (14:25-15:25) Pamela N. Munster
TARGETING NOVEL INDICATIONS (16:30-19:30) Pamela N. Munster
TARGETING NOVEL INDICATIONS: Combination HDAC Therapies in Solid Tumors (17:00-17:30) Pamela N. Munster
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.